Hypercholesterolemia Interferes with Induction of miR-125b-1-3p in Preconditioned Hearts.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 May 2020
Historique:
received: 31 03 2020
revised: 19 05 2020
accepted: 20 05 2020
entrez: 30 5 2020
pubmed: 30 5 2020
medline: 17 2 2021
Statut: epublish

Résumé

Ischemic preconditioning (IPre) reduces ischemia/reperfusion (I/R) injury in the heart. The non-coding microRNA miR-125b-1-3p has been demonstrated to play a role in the mechanism of IPre. Hypercholesterolemia is known to attenuate the cardioprotective effect of preconditioning; nevertheless, the exact underlying mechanisms are not clear. Here we investigated, whether hypercholesterolemia influences the induction of miR-125b-1-3p by IPre. Male Wistar rats were fed with a rodent chow supplemented with 2% cholesterol and 0.25% sodium-cholate hydrate for 8 weeks to induce high blood cholesterol levels. The hearts of normo- and hypercholesterolemic animals were then isolated and perfused according to Langendorff, and were subjected to 35 min global ischemia and 120 min reperfusion with or without IPre (3 × 5 min I/R cycles applied before index ischemia). IPre significantly reduced infarct size in the hearts of normocholesterolemic rats; however, IPre was ineffective in the hearts of hypercholesterolemic animals. Similarly, miR-125b-1-3p was upregulated by IPre in hearts of normocholesterolemic rats, while in the hearts of hypercholesterolemic animals IPre failed to increase miR-125b-1-3p significantly. Phosphorylation of cardiac Akt, ERK, and STAT3 was not significantly different in any of the groups at the end of reperfusion. Based on these results we propose here that hypercholesterolemia attenuates the upregulation of miR-125b-1-3p by IPre, which seems to be associated with the loss of cardioprotection.

Identifiants

pubmed: 32466450
pii: ijms21113744
doi: 10.3390/ijms21113744
pmc: PMC7312064
pii:
doi:

Substances chimiques

MIRN125 microRNA, rat 0
MicroRNAs 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
ID : K115990
Organisme : European Union and the European Regional Development Funds
ID : GINOP 2.3.2-15-2016-00006; EFOP 3.6.2-16-2017-00006
Organisme : Emberi Eroforrások Minisztériuma
ID : 20391 3/2018/FEKUSTRAT
Organisme : Magyar Tudományos Akadémia
ID : BO/00522/19/8
Organisme : Ministry for Innovation and Technology
ID : ÚNKP-19-3-SZTE-269, ÚNKP-18-4-SZTE-63, ÚNKP-19-4-SZTE-89, ÚNKP-19-4-SZTE-8

Références

Circulation. 1986 Nov;74(5):1124-36
pubmed: 3769170
Eur Heart J. 2020 Jan 1;41(1):12-85
pubmed: 31820000
Mol Cell Biochem. 1998 Sep;186(1-2):27-34
pubmed: 9774182
J Mol Cell Cardiol. 1997 Dec;29(12):3321-33
pubmed: 9441838
Circulation. 2016 Jan 19;133(3):291-301
pubmed: 26585673
Genome Biol. 2010;11(10):R106
pubmed: 20979621
Cardiovasc Res. 2007 Oct 1;76(1):100-9
pubmed: 17658498
J Pharmacol Exp Ther. 2006 Jan;316(1):154-61
pubmed: 16166272
Circ Res. 2018 Aug 17;123(5):564-578
pubmed: 29921652
Am J Physiol Heart Circ Physiol. 2012 Nov 15;303(10):H1229-36
pubmed: 22982778
Circ Res. 2011 Nov 11;109(11):1302-8
pubmed: 21980124
Int J Mol Sci. 2018 Nov 12;19(11):
pubmed: 30424579
J Am Coll Cardiol. 1999 Dec;34(7):2120-5
pubmed: 10588233
J Pharmacol Toxicol Methods. 2010 Mar-Apr;61(2):163-70
pubmed: 20188845
Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1207-12
pubmed: 19461052
Sci Rep. 2019 Feb 4;9(1):1302
pubmed: 30718600
Circ Res. 2015 Feb 13;116(4):674-99
pubmed: 25677517
Nucleic Acids Res. 2012 Jan;40(1):37-52
pubmed: 21911355
Mol Cell Biochem. 2020 Mar;466(1-2):139-148
pubmed: 32016695
J Mol Cell Cardiol. 2013 Sep;62:111-21
pubmed: 23722270
Cell Physiol Biochem. 2018;45(5):2107-2121
pubmed: 29533954
Cell Biol Int. 2016 Nov;40(11):1224-1234
pubmed: 27592695
Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H216-27
pubmed: 24858849
J Mol Cell Cardiol. 2018 Jan;114:72-82
pubmed: 29122578
J Cell Physiol. 2019 May;234(5):6182-6193
pubmed: 30370578
Cardiovasc Res. 2013 Jan 1;97(1):33-43
pubmed: 22977010
Br J Pharmacol. 2015 Jul;172(14):3472-83
pubmed: 25827015
Lipids Health Dis. 2013 Sep 25;12:138
pubmed: 24063587
Mol Med. 2010 Jul-Aug;16(7-8):307-15
pubmed: 20383434
J Mol Cell Cardiol. 2016 Oct;99:138-150
pubmed: 27515282
Oxid Med Cell Longev. 2016;2016:3863726
pubmed: 26788247
Circ Res. 2009 Mar 13;104(5):572-5
pubmed: 19213952
Theranostics. 2018 Nov 29;8(22):6163-6177
pubmed: 30613290
BMC Genet. 2013 Mar 06;14:18
pubmed: 23497314
Biochem Biophys Res Commun. 2018 Nov 17;506(1):130-136
pubmed: 30340830
Cardiovasc Res. 1998 Jan;37(1):21-33
pubmed: 9539854
Front Oncol. 2019 Jul 16;9:598
pubmed: 31380269
Cardiovasc Res. 2014 Jun 1;102(3):385-95
pubmed: 24576954
Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375
pubmed: 31163980
RNA. 2011 Feb;17(2):312-26
pubmed: 21177881
Chest. 2005 Sep;128(3):1623-8
pubmed: 16162767
Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H405-13
pubmed: 24285110
Atherosclerosis. 2006 Oct;188(2):356-62
pubmed: 16376892

Auteurs

Márton R Szabó (MR)

Metabolic Diseases and Cell Signaling (MEDICS) Research Group, Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm tér 9., H-6720 Szeged, Hungary.
Interdisciplinary Centre of Excellence, University of Szeged, Dugonics tér 13., H-6720 Szeged, Hungary.

Renáta Gáspár (R)

Metabolic Diseases and Cell Signaling (MEDICS) Research Group, Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm tér 9., H-6720 Szeged, Hungary.
Interdisciplinary Centre of Excellence, University of Szeged, Dugonics tér 13., H-6720 Szeged, Hungary.

Márton Pipicz (M)

Metabolic Diseases and Cell Signaling (MEDICS) Research Group, Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm tér 9., H-6720 Szeged, Hungary.
Interdisciplinary Centre of Excellence, University of Szeged, Dugonics tér 13., H-6720 Szeged, Hungary.

Nóra Zsindely (N)

Department of Microbiology, Faculty of Science and Informatics, University of Szeged, Közép fasor 52., H-6726 Szeged, Hungary.

Petra Diószegi (P)

Metabolic Diseases and Cell Signaling (MEDICS) Research Group, Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm tér 9., H-6720 Szeged, Hungary.
Interdisciplinary Centre of Excellence, University of Szeged, Dugonics tér 13., H-6720 Szeged, Hungary.

Márta Sárközy (M)

Metabolic Diseases and Cell Signaling (MEDICS) Research Group, Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm tér 9., H-6720 Szeged, Hungary.
Interdisciplinary Centre of Excellence, University of Szeged, Dugonics tér 13., H-6720 Szeged, Hungary.

László Bodai (L)

Department of Biochemistry and Molecular Biology, Faculty of Science and Informatics, University of Szeged, Közép fasor 52., H-6726 Szeged, Hungary.

Tamás Csont (T)

Metabolic Diseases and Cell Signaling (MEDICS) Research Group, Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm tér 9., H-6720 Szeged, Hungary.
Interdisciplinary Centre of Excellence, University of Szeged, Dugonics tér 13., H-6720 Szeged, Hungary.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH